Search - tctmd.com

Displaying 61 - 80 of 213

Sort: Relevancy | Date

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Conceptual Overview: Pros and Cons

Presenter: Michael Reardon

June 14, 2019

Presentation TVT 2019

Leaflet Chordal Suspension for Primary MR Will Become and Remain an Important Tool in the Surgical/Interventional Toolbox

Presenter: Michael Reardon

June 14, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Does Surgical Risk Still Matter When Evaluating for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

Surgical Editorial Insights

Presenter: Michael Reardon

June 12, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

Presentation SIF 2019

Next Generation TAVR Devices

Presenter: Michael J Reardon

March 30, 2019

Presentation SIF 2019

Top 4 Structural Trials of the Last Year

Presenter: Michael J Reardon

March 27, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

Podcast Rox Heart Radio

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

February 13, 2019

Presentation TCT 2018

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Presenter: Michael J. Mack, David W.M. Muller, Michael J. Reardon

September 24, 2018

Presentation TCT 2018

Secondary Mitral Regurgitation With Severely Reduced LVEF

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Presentation TCT 2018

Bicuspid Aortic Stenosis: How To Treat

Presenter: Vinayak Bapat, Susheel K. Kodali, Philippe Genereux, Martin B. Leon, Scott Lim, Michael J. Mack, Raj Makkar, Patrick T. O'Gara, Michael J. Reardon, Allan Schwartz

September 23, 2018

Advertisement

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Conceptual Overview: Pros and Cons

Leaflet Chordal Suspension for Primary MR Will Become and Remain an Important Tool in the Surgical/Interventional Toolbox

Illustrative Cases

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Does Surgical Risk Still Matter When Evaluating for TAVR?

Surgical Editorial Insights

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Next Generation TAVR Devices

Top 4 Structural Trials of the Last Year

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Primary Results From the Evolut Low Risk Trial

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

Intrepid: Device Attributes, Implant Procedure, Clinical Results, and APOLLO Design and Status

Secondary Mitral Regurgitation With Severely Reduced LVEF

Bicuspid Aortic Stenosis: How To Treat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content